Health glossary · Cancer

Genetic Testing

juh-NET-ik TES-tingnoun phrase

Laboratory analysis of your DNA to look for inherited mutations that may raise your risk of certain diseases.

Genetic testing examines your DNA — usually from a blood or saliva sample — to look for specific changes (mutations) in genes that are associated with inherited conditions or elevated disease risk. In cancer care, it is most commonly used to identify mutations in genes like BRCA1, BRCA2, and others linked to hereditary breast, ovarian, and colorectal cancer syndromes.

Part of speechnoun phrase
Pronunciationjuh-NET-ik TES-ting
OriginGreek genesis (origin, creation) + Old French tester (to test), from Latin testis (witness). Modern genetic testing became clinically available in the 1990s with advances in DNA sequencing.

What is genetic testing?

Genetic testing analyzes your DNA to search for specific inherited variants — changes in genes that may increase your risk of developing certain conditions. The test itself is straightforward from a patient perspective: a sample of blood or saliva is collected, sent to a specialized laboratory, and analyzed. Results typically return within a few weeks. The complexity lies not in collecting the sample but in interpreting what the results mean for you and your family.

Several types of results are possible. A positive result means a known harmful mutation was found — not that you have cancer, but that your risk is meaningfully elevated above average. A negative result means no known harmful mutation was detected in the genes tested, though it does not eliminate all risk (since not all cancer-causing mutations are yet known, and not all genes may have been tested). A variant of uncertain significance (VUS) means a change was found in the DNA, but scientists do not yet know whether it is harmful — a genuinely uncertain result that can be updated as research advances.

Panel testing — analyzing dozens of cancer-risk genes simultaneously — has become increasingly common and affordable. Genes tested may include BRCA1, BRCA2, PALB2, CHEK2, ATM, CDH1, PTEN, MLH1, MSH2, and others, depending on the panel. Each gene confers a different degree of risk elevation, and not all are equally well understood. This is one of the reasons genetic counseling before and after testing is so valuable — the interpretation is rarely simple.

Why it matters

Genetic testing has the potential to be genuinely transformative — giving you advance knowledge of elevated risk that allows you to act before a cancer develops. People who test positive for BRCA1 or BRCA2 mutations, for example, have a range of evidence-based options: more intensive surveillance with alternating mammography and MRI, chemoprevention with medications that reduce risk, or risk-reducing surgery (prophylactic mastectomy or salpingo-oophorectomy). Each of these strategies has tradeoffs, and none is the right choice for everyone — but having the information means having the choice.

Testing also has implications beyond you. A BRCA mutation is inherited, meaning your parents, siblings, and children each have a 50 percent chance of carrying the same mutation. Sharing genetic information with family members — while navigating the emotional complexity that comes with that — is one of the most significant ripple effects of a positive result. Genetic counseling helps you think through how and when to have those conversations, and what they might mean for the people you love.

Related terms

Related articles